drug · small molecule
patient view →FLUTICASONE PROPIONATE
Phase 3updated 2mo agoby Paratek Pharmaceuticals Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 14 investigational indications.
targets
Glucocorticoid receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that